News/ News/ Sales and Marketing Inozyme plans $75m IPO as it heads for clinic with rare bone diseases drug Richard Staines bone, Inozyme, IPO, Rare diseases 0 Comment US biotech Inozyme Pharma is the latest to jump on to the IPO bandwagon, setting terms for a Share X Inozyme plans $75m IPO as it heads for clinic with rare bone diseases drug https://pharmaphorum.com/news/inozyme-plans-75-ipo-as-it-heads-for-clinic-with-rare-bone-diseases-drug/
